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Abstract
Worldwide consumption of opioids remains at historic levels. Preclinical studies
report intergenerational effects on the endogenous opioid system of future progeny
following preconception morphine exposure. Given the role of endogenous opioids in
energy homeostasis, such effects could impact metabolism in the next generation.
Thus, we examined diet‐induced modifications in F1 male progeny of morphine‐
exposed female rats (MORF1). When fed a high fat‐sugar diet (FSD) for 6 weeks,
MORF1 males display features of emerging metabolic syndrome; they consume more
food, gain more weight, and develop fasting‐induced hyperglycemia and
hyperinsulinemia. In the hypothalamus, proteins involved in energy homeostasis are
modified and RNA sequencing revealed down‐regulation of genes associated with
neuronal plasticity, coupled with up‐regulation of genes associated with immune,
inflammatory, and metabolic processes that are specific to FSD‐maintained MORF1
males. Thus, limited preconception morphine exposure in female rats increases the
risk of metabolic syndrome/type 2 diabetes in the next generation.
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1 | INTRODUCTION
The percentage of the general population exposed to prescription opi-
oids has increased dramatically over the past decade.1,2 Such broad‐
based opioid exposure has led to millions of people living with opioid
use disorders and tens of thousands dying from opioid overdoses.3
While such immediate outcomes remain the highest public health pri-
ority, additional effects of widespread prescription opioid use within
the general population remain unknown. While perhaps not commonly
appreciated, in addition to their analgesic and hedonic properties, opi-
oids also produce significant neuroendocrine, immune, and metabolic
effects.4 These effects are due to the modulatory role that endoge-
nous opioids play in an array of homeostatic processes.5 Thus, expo-
sure to exogenous opioids may induce modifications in the
endogenous opioid system that impact diverse homeostatic mecha-
nisms beyond those classically associated with opioid addiction.
We previously demonstrated that female opioid exposure in rats,
restricted to a 10‐day period during adolescence, alters the develop-
ment of the reproductive axis, delaying sexual maturation and
resulting in transcriptional modifications in the hypothalamus that per-
sist for months after this discrete exposure period.6 Moreover, we
observe significant sex‐specific effects in the progeny of adolescent
morphine‐exposed females, despite the fact that females are drug free
for several weeks prior to mating. Our initial studies primarily focused
on effects related to drug sensitivity with a primary emphasis on
reward systems. These studies revealed significant alterations in both
the F1 and F2 generation,6-11 supporting the hypothesis that adoles-
cent morphine exposure can trigger transgenerational effects main-
tained for at least two generations.
In these previous studies, altered opioid‐mediated regulation of
homeostatic processes regulated within the hypothalamus were
observed and those effects persisted for two generations in male,
but not female, offspring of morphine‐exposed females (MORF1
males).12 Additional studies found that proopioimelanocortin (Pomc)
gene expression was up‐regulated in both adolescent and adult
MORF1 males, but not MORF1 females.10,13 The hypothalamic
opiomelanocortin system originates in the arcuate nucleus (ARC),
where several neuropeptides involved in the regulation of sexual mat-
uration, bodyweight, and metabolism are produced.14-16 Previous
findings in both animals and humans suggest that changes in the reg-
ulation of POMC neurons may play an important role in
transgenerational epigenetic effects associated with parental nutri-
tion.17 Thus, given the role of POMC as a critical regulator of meta-
bolic homeostasis and the transgenerational effect on Pomc
expression observed in MORF1 males, we hypothesized that discrete
exposure to morphine prior to conception will alter hypothalamic reg-
ulation of metabolic processes in future male offspring.
To test this hypothesis, we examined F1 male offspring maintained
on a diet containing increased fat and sugar as compared with those
on a standard control diet (CD). Endpoints included the timing of sex-
ual maturation, body weight gain, feeding, and locomotion. We next
examined fasting blood glucose levels and plasma concentrations of
insulin and corticosterone (CORT), which are both important
glucoregulatory factors.18 Based on significant F1 differences, we also
examined expression of ARC POMC and the orexigenic polypeptide
neuropeptide Y (NPY), as well as ARC POMC‐derived α‐MSH and β‐
EP concentration in select target sites. Finally, to further elucidate
likely mechanisms behind the observed differences, the ARC tran-
scriptome was analyzed to identify functional pathways in F1 males
modified by maternal opioid history in a diet‐specific manner. Collec-
tively, our findings demonstrate that opioid exposure in females, even
when that exposure occurs prior to conception, increases the risk of
diet‐induced type 2 diabetes in their adult male offspring and that
these effects are associated with significant alterations in transcrip-
tional pathways that regulate metabolic, immune, and
neurodevelopmental processes within the ARC.
2 | MATERIALS AND METHODS
2.1 | Experimental subjects
2.1.1 | Adolescent morphine exposure
For all experiments, 22‐day‐old female Sprague‐Dawley rats [Crl:CD
(SD)BR] were purchased from Charles River Breeding Laboratories
and grouped housed in light (on 600‐1800 hours) and temperature
(21°C‐24°C) regulated rooms with ad libitum access to food and
water. Adolescent rats were administered morphine (MORF0; n =
36) or saline (SALF0; n = 36) beginning on postnatal day 30 (PND30)
for 10 days, which corresponds to the early‐midadolescent phase in
humans.19 Morphine was administered daily between 9:00 and
10:00 AM using an intermittent, increasing dose regimen of morphine
that increased every other day (5, 10, 15, 20, and 25 mg/kg; sc).
SALF0 females were administered saline at equivalent volumes. This
study was performed in three independent cohorts.
2.1.2 | Mating
All F0 females remained drug free for at least 3 weeks after the final
morphine injection and were subsequently mated as adults (after
PND60) with drug‐naïve colony males. On the day following parturi-
tion (PND1), litters were culled to five males and five females housed
together until weaning. On PND21 litters were weaned, housed with
same sex littermates, and transitioned to standard rodent chow. Given
our previous findings indicating that male but not female MORF1 ani-
mals demonstrate significant differences in POMC gene expression
and hypothalamic dysregulation in response to exogenous opioids,
these studies were conducted in male offspring. For every experimen-
tal group, only one male from each litter was used to limit potential lit-
ter effects.
2.2 | Experimental procedures
2.2.1 | Diets and bodyweights
On PND30, MORF1 and SALF1 males were transitioned to a CD (3.8
kcal/gm ) consisting of 10% fat/0 % sucrose (D12450K; Research
diets, New Brunswick, NJ) or a high fat‐moderate sucrose diet (fat‐
sugar diet [FSD]) (4.7 kcal/gm ) consisting of 45% fat/17 % sucrose
diet (D12451; Research diets) for a period of 6 weeks. Individual
bodyweights (grams) were taken weekly throughout the study with
bodyweight gain calculated as PND72‐PND30.
2.2.2 | Sexual maturation
The onset of puberty was measured using preputial separation.20
Beginning on PND30, subjects were examined once daily for skin‐fold
separation via gentle retraction of the prepuce membrane with
sexual maturation defined as the first date of complete preputial
retraction.
2.2.3 | Caloric consumption
Grouped house animals were fed their respective diets for 6 weeks,
after which individual animals were transferred to a clean cage
with 300 g of food provided. Twenty‐four hours later, the remaining
food, including any pellets on the cage floor, was weighed and
caloric consumption was calculated by subtracting final food weight
from initial food weight multiplied by 3.8 kcal for CD and 4.7 kcal
for FSD.
2.2.4 | Locomotor activity
On PND72 home cages were individually placed into activity frames at
10:00 AM. Following a 2‐hour acclimation period activity was moni-
tored for 24 hours using the SmartFrame Motor Monitor System
(Hamilton‐Kinder; Poway, CA), with free access to food and water
throughout. Activity data were analyzed as distance travelled (cm)
based on sequential photobeam breaks.
2.2.5 | Blood and brain collections
Between PND70‐72, all animals were fasted overnight (16 hours).
Between 9:00 and 10:00 AM, animals were transferred to a procedure
room (transit <60 seconds), exposed briefly to CO2, and decapitated.
Blood glucose levels were measured immediately from trunk blood
using a standard glucometer (CVS, MA) with remaining trunk blood
collected into heparinized tubes. Brains were removed, rapidly frozen
in −20°C in 2‐methylbutane, and stored at −80°C. Heparinized blood
was centrifuged, and plasma was stored at −20°C. For protein and
peptide analysis, brains were cryostat‐mounted and 1‐mm 3 bilateral
micropunches were taken from the ARC (A/P −2.3; M/L ± 1; V/D −8
mm), PVN (A/P −1.3; M/L ± 0.5; V/D −6.8 mm), and VTA (A/P −4.7;
M/L ± 1.5; V/D −8.2 mm; all coordinates relative to Bregma).
2.2.6 | Western blotting
Tissue punches were homogenized in Pierce immunoprecipitation lysis
buffer (Thermo Fisher Scientific, Waltham, MA) supplemented with 1×
proteinase inhibitor cocktail and 1μM PMSF, and total protein content
quantified via Pierce BCA protein assay (Thermo Fisher) according to
manufacturer's recommendations. Total protein (20 μg) was separated
in a 4% to 12% Tris‐Bis gel (NuPage Novex, Thermo Fisher) and trans-
ferred to a nitrocellulose membrane (Thermo Fisher). Membranes
were washed, blocked in 5% bovine serum albumin (BSA) or nonfat
milk for 1 hour, and incubated overnight at 4°C in primary antibodies
recognizing either NPY (Cell Signaling, D7Y5A XP; Danvers MA),
POMC (Abcam, ab180766; Cambridge, MA), or β‐actin (Abcam,
ab6721). The next day, membranes were washed and incubated in
the appropriate HRP‐secondary antibody (2 hours at room tempera-
ture), enhanced with chemiluminescence solution (Pierce ECL West-
ern Blotting substrate; Thermo Fisher scientific), and imaged (Bio‐
Rad Universal Hood II ChemiDoc XRS) with densitometry determined
in ImageJ (NIH; Bethesda, MD). Antibody specificity was probed using
purified peptide (Recombinant Human POMC protein Ab108118 and
NPY endogenous neuropeptide Ab120208). Both were run in isolation
and in arcuate lysates spiked with the peptide. In addition, both dilu-
tion curves and negative controls were utilized.
2.2.7 | Enzyme immunosorbent assays
Quantification of α‐MSH (EK04301; Phoenix Pharmaceuticals; Burlin-
game, CA), β‐EP (EK02233; Phoenix Pharmaceuticals), insulin (Crystal
Chem, 90060; Downers Grove, IL), and corticosterone (Abcam;
ab108821) was performed using commercially available EIA kits.
Assays were performed according to the manufacturer's suggestions.
Intra‐assay and interassay CV of both α‐MSH and β‐EP EIA's are
<10% and <15%, 5.3% and 10.6% for corticosterone EIA, and < 10%
and < 10% for insulin EIA
2.3 | Arcuate nucleus RNA sequencing
A separate cohort of SALF1 and MORF1 animals were generated,
maintained on the respective diets for 6 weeks, overnight fasted,
and euthanized the following day. Bilateral ARC tissue was collected
as described above (N = 6/group ). Total RNA was extracted using
the Qiazol RNA extraction kit (Qiagen) and 2 μg of total RNA was puri-
fied for mRNA. Isolated mRNA was further subjected to fragmenta-
tion, cDNA synthesis, adapter ligation, purification, and enrichment
reactions (Illumina TruSeq Stranded mRNA sample preparation kit;
Illumina) to generate an equimolar cDNA library; 51‐bp single‐end
reads were generated on an Illumina HiSeq2500 Sequencer at the
Tufts University Core Facilities (TUCF) Genomics Core (Boston, MA,
USA).
2.3.1 | RNA‐seq mapping and normalization
Reads were aligned to the reference genome Rattus norvegicus 6.0
using the STAR alignment software, v2.5.3a.21 Aligned reads were
counted against gene model annotation (Ensembl v92) to obtain
expression values using the STAR gene‐counts option. The three sam-
ples with fewer than 10 million reads uniquely aligned to the anno-
tated transcriptome were discarded. Read counts were normalized
using the trimmed mean of M values (TMM) normalization method.22
2.4 | Statistical analyses
2.4.1 | Behavioral and physiological endpoints
The results for each treatment are presented as mean ± SEM. Most
data sets were analyzed using a two‐way analysis of variance
(ANOVA) with maternal opioid history and diet as factors with post
hoc effects examined using Holms‐Sidak multiple comparisons test.
Even in the absence of significant interactions, planned comparisons
regarding the effects of maternal treatment within diet condition were
conducted.23 β‐EP data between diet conditions violated normality
that could not be eliminated via transformation. Thus, these data were
analyzed using two‐tailed t tests within each dietary condition. For
nonparametric data, a Mann‐Whitney U sum of ranks test was per-
formed, while two‐tailed t tests with Welch correction were per-
formed for data sets displaying unequal variances. For data sets
analyzed nonparametrically, graphs are presented using mean ± SEM
for continuity of data presentation. Preputial separation data were
analyzed using a chi‐square test on the percent of subjects displaying
initial preputial separation by day. For all analyses, significance was
defined as P <.05.
2.4.2 | RNA sequencing
Genes with a count of at least one in at least six samples, and a count
of at least 10 in at least one sample, were retained for differential
expression analysis. The EdgeR generalized linear model was used to
analyze differential expression.24 Differentially expressed genes were
identified using an adjusted false discovery rate (FDR) q value < 0.05.
Functional enrichment of Gene Ontology Biological Process terms in
the sets of differentially expressed genes was identified using the
ClusterProfiler R package.25 Gene set enrichment analysis (GSEA)
was further applied for pairwise comparisons between classes, using
the curated gene sets (MSigDB c2) and the transcription factor target
gene sets (c3) (http://www.broadinstitute.org/gsea/index.jsp).26 Sig-
nificance of the enrichment under GSEA was assessed based on
1000 gene set permutations and was FDR adjusted. We reported all
gene sets including between five and 500 genes with FDR < 0.1.
Molecular interactions shown in Figure 5D reflect either MSigDB c2
TF‐target relationships or protein‐protein interactions from the
STRING database.27 We used only interactions derived from experi-
mental evidence, with confidence score ≥ 400, in rat or transferred
from orthologs in other organisms.
3 | RESULTS
Using an established model of discrete female adolescent morphine
exposure, we determined the impact of preconception opioid expo-
sure on metabolic‐related processes in adult male offspring (see
Figure 1A). It is important to note that no differences in fertility or
fecundity, litter size, sex distribution, birth weight, postnatal weight
gain, or timing of postnatal developmental milestones (tooth eruption
or eye opening) have been observed in this phenotype.7,10 As demon-
strated in Figure 1B, however, preputial separation data revealed
delayed sexual maturation in MORF1 males irrespective of diet ([χ2
(1,N = 99) = 14.97, P <.001; PND39] and [χ2 (1,N = 99) = 7.64, P
=.006; PND40]). As shown in Figure 1C, there were significant main
effects of both maternal opioid history and diet ( F 1,95 = 5.38; P <.03
and F 1,95 = 17.47; P <.0001, respectively) with a trend toward an
FIGURE 1 Sexual development and energy balance profile. A, Outline of experimental design. B, Percent separated F1 animals at postnatal days
35‐44. MORF1's displayed delayed indices separation as compared with SALF1's. C, Mean ± SEM, bodyweight gain between PND30 and PDN72
following 6‐wk control diet (CD) or high fat‐sugar diet (FSD). FSD‐MORF1s displayed elevated bodyweight compared with SALF1 males, whereas
F1s fed a control diet gain comparable weight. *P < .05, N = 24‐25. D, Mean ± SEM, 24‐h caloric consumption was assessed in post 6‐wk diet
maintenance, N = 11‐12. FSD‐MORF1s consumed more food than FSD‐SALF1s, while F1s consumed similar amounts when fed a CD. E, Mean ±
SEM, locomotor activity in MORF1 and SALF1s assessed following CD or FSD. Main effect of time across diet conditions. *P < .05, N = 9/group
interaction ( F 1,95 = 3.2; P =.08) on body weight gain between the start
of the diet and the day of sacrifice (PND30‐PND72). Planned compar-
isons revealed that MORF1 males gained significantly more weight in
comparison with SALF1 males when maintained on a diet containing
elevated levels of fat and sugar (t1,95 = 2.95; P <.01). Additionally,
when body weight data were examined overtime, there was a signifi-
cant main effect of time ( F 7,588 = 7889, P <.001) as well as maternal
opioid history ( F 7,588 = 4.55, P <.001), time by diet ( F 7,588 = 10.55,
P <.001) and time by maternal opioid history F 7,588 = 3.03, P <.01
(see Data S1; Figure 1).
As changes in bodyweight could be due in part to changes in feed-
ing behavior or activity levels, F1 males were examined for changes in
these parameters. Caloric intake monitored over 24 hours revealed
significant main effects of both maternal opioid history and diet
( F 1,41 = 8.80, P <.006; F 1,41 = 8.45; P <.007, respectively), with no
significant interaction ( F 1,41 = 1.92; P =.17; Figure 1D). Planned com-
parisons indicated that FSD‐fed MORF1 males consumed more calo-
ries than FSD‐fed SALF1 males (t1,41 = 3.05; P <.01). In contrast, as
represented in Figure 1E, locomotor activity followed the expected
circadian rhythm with a main effect of time observed under each die-
tary condition ( F 23,368 = 6.93, P <.001 [CD] and F 23,368 = 7.22, P
<.001 [FSD]). However, there were no main effects of maternal opioid
history under either diet condition ( F 1,16 = 2.67, P =.12 [CD] and
F 1,16 = 0.45, P =.51 [FSD]) and no time by maternal opioid history
interaction ( F 23,368 = 0.59, P =.94 [CD] and F 23,368 = 0.98, P =.48
[FSD]).
Plasma from fasted SALF1 and MORF1 males was examined for
potential alterations in glucose homeostasis. As shown in Figure 2A,
there were significant main effects of maternal opioid history and diet
as well as a significant interaction ( F 1,40 = 6.79; P <.02; F 1,40 = 4.33; P
<.05 and F 1,40 = 4.52; P <.04, respectively). Post hoc analysis revealed
significantly elevated fasting glucose in MORF1 relative to SALF1
males following FSD (t1,40 = 3.425; P <.01). We next tested levels of
insulin, as a potential mechanism mediating the hyperglycemia
displayed in the MORF1 group. As depicted in Figure 2B, there were
no significant main effects of maternal opioid history or diet condition
( F 1,62 = 0.04, P =.85; F 1,62 = 0.25, P =.62, respectively); however,
there was a significant interaction ( F 1,62 = 5.99, P <.02), with post
hoc analysis revealing elevated insulin levels in FSD‐maintained
MORF1 males compared with FSD‐maintained SALF1 males (t1,62 =
2.20, P <.05). Finally, as demonstrated in Figure 2C, there was a main
effect of maternal opioid history ( F 1,43 = 5.03; P <.04) on plasma
CORT levels. There was no main effect of diet and no interaction
( F 1,43 = 0.71, P =.41; F 1,43 = 1.27, P =.27, respectively); however, post
hoc analyses revealed that MORF1 males had significantly elevated
CORT in comparison with SALF1 males only under FSD conditions
(t1,43 = 2.37; P <.05).
As central regulators of energy homeostasis, NPY and POMC poly-
peptides in the ARC were measured to examine their roles in mediat-
ing bodyweight/feeding behavior and glucose regulation in MORF1
male progeny. We assessed both proNPY (precursor to the bioactive
NPY peptide) and NPY levels. As shown in Figure 3A, there was a sig-
nificant effect of maternal opioid history on proNPY expression ( F 1,44
= 7.48; P <.01) with no effect of diet and no interaction ( F 1,44 = 0.14;
P =.07; F 1,44 = 0.35; P =.56). Post hoc analysis revealed that MORF1
males under CD conditions displayed significantly more proNPY (t1,44
= 2.30; P <.05). With regard to NPY levels (Figure 3B), there was a
trend toward a main effect of maternal opioid history, a main effect
of diet, and a significant maternal opioid history by diet interaction
( F 1,46 = 3.65; P =.06; F 1,46 = 9.06; P <.005; F 1,46 = 4.15; P <.05,
respectively). Post hoc analysis indicated that MORF1 males exhibit
significantly increased levels of NPY when compared with SALF1
males under FSD conditions (t1,46 = 2.73; P <.05).
As shown in Figure 4A, POMC levels in the ARC revealed no signif-
icant main effects of maternal opioid history or diet ( F 1,46 = 3.21, P
=.08; F 1,46 = 1.09; P =.30, respectively). There was, however, a signif-
icant maternal opioid history by diet interaction ( F 1,46 = 6.34; P <.02),
with post hoc analysis revealing significantly higher levels of POMC
within the ARC of MORF1 males relative to SALF1 males under CD
conditions (t1,40 = 2.99; P <.01). As we have previously observed sig-
nificantly increased Pomc expression in MORF1 males,10 we next
determined whether increased POMC levels under standard diet
FIGURE 2 Fasting glucose, insulin, and corticosterone levels. A, Mean ± SEM, fasting glucose levels (mg/dL). Following a 16‐h fast, glucose levels
were measured. Fat‐sugar diet (FSD)‐MORF1s exhibit elevated fasting glucose whereas control diet (CD)‐F1s display comparable levels. *P < .05,
**P < .01, N = 10‐12. B, Mean ± SEM, plasma insulin levels were assessed (pg/mL). FSD‐fed MORF1s exhibit elevated fasting insulin while CD‐fed
F1s exhibit similar plasma insulin. *P < .05, N = 13‐18. C, Mean ± SEM, fasting corticosterone levels (ng/mL). FSD‐MORF1s exhibit elevated
corticosterone compared with FSD‐SALF1s while CD‐fed F1s display comparable levels of plasma corticosterone. *P < .05, N = 10‐14
conditions might relate to epigenetic programming of Pomc regulation.
Thus, we performed DNA methylation analysis across the rat Pomc
locus. However, this revealed no significant differences within the
promoter, exon 2 or exon 3 CpG islands between SALF1 and MORF1
males (Data S1).
As we observed differences in POMC levels under specific diet
conditions based on maternal opioid history, we next examined levels
of peptides cleaved from POMC known to regulate energy balance.
Namely, α‐MSH and β‐EP peptides were measured within the PVN
and VTA where they are known to facilitate changes in feeding behav-
iors. In the VTA, there was no effect of maternal drug history on β‐EP
under CD conditions (Mann U: 29; P <.21); however, there was a sig-
nificant effect of maternal drug history within FSD conditions (t1,17 =
2.37; P =.03), with MORF1 males displaying higher levels of β‐EP
(Figure 4B). In contrast, there were no effects of maternal morphine
history or diet and no interaction on α‐MSH levels within the VTA
( F 1,35 = 00992, P =.75; F 1,35 = 2.33, P =.14; F 1,35 = 0.0009, P =.98,
respectively; Data S1; Figure 2). However, within the PVN, there
was a significant main effect of maternal drug history on α‐MSH
levels, with no effects of diet or maternal drug history by diet interac-
tion (Figure 4C; F 1,34 = 4.29, P <.05; F 1,34 = 0.006, P =.94; F 1,34 =
2.13; P =.15, respectively).
Given that the significant effects of maternal opioid history on F1
bodyweight gain, feeding behavior, and glucose regulation were asso-
ciated with diet‐specific alterations in neuronal populations within the
ARC critical for the regulation of energy homeostasis (POMC and
NPY), we wanted to further elucidate potential mechanisms underly-
ing these alterations. We therefore performed RNA sequencing of
ARC tissue in a new cohort of animals to identify molecular pathways
affected by maternal opioid history and diet. All animals were exam-
ined following a 16‐hour (overnight) fast to correspond to data show-
ing glucose dysregulation. Expression data were initially analyzed
using EdgeR to identify individual differentially expressed genes via a
multifactorial analysis, with maternal opioid history and diet as factors.
This analysis yielded 168 significantly differentially expressed genes
between MORF1 and SALF1 FSD‐maintained males (see Figure 5A).
FIGURE 3 ARC proNPY and NPY levels. A,
Mean ± SEM, proNPY relative to β‐actin.
Control diet (CD)‐ and FSD‐fed MORF1s
display increased proNPY polypeptide. B, NPY
relative to β‐actin. Fat‐sugar diet (FSD)‐fed
MORF1 males display increased NPY,
whereas similar levels are observed between
F1s fed a CD. *P < .05, N = 11‐14
FIGURE 4 POMC, MSH, and β‐EP levels in F1 hypothalamus and midbrain. A: Mean ± SEM, ARC POMC relative to β‐actin. MORF1 males
display elevated POMC relative to SALF1 on a control diet, *P < .05, N = 8‐10. B, Mean ± SEM, α‐MSH in PVN. Control diet‐fed MORF1
males display reduced α‐MSH levels in PVN, *P < .05, N = 7. D: Mean ± SEM, α‐MSH in the VTA. Fat‐sugar diet (FSD)‐fed MORF1s displayed
elevated β‐EP compared with SALF1s, *P < .05, N = 7‐11
Of these 168 genes, 119 were significantly up‐regulated in MORF1,
and 57 were down‐regulated. No significantly differentially expressed
individual genes were identified in any of the other comparisons (eg,
MORF1 vs SALF1 CD‐maintained, FSD vs CD either with or without
FIGURE 5 RNA‐seq transcriptome analysis from the arcuate nucleus. All comparisons are between SALF1 and MORF1 maintained on fat‐sugar
diet (FSD). A, A volcano plot presenting all expressed genes (q value < 0.05). Blue = down‐regulated; Red = up‐regulated. Those 168 differentially
expressed genes (DEGs) with regularized‐logarithm transformed count value are shown in the adjacent heat map. The two groups of rats (SALF1
and MORF1) were separated using hierarchical clustering. Gene Ontology (GO) terms enriched in down‐regulated B, and up‐regulated C, DEGs.
Hierarchical clustering identified functional groups based on similarity of differential genes in each term and are organized by color. D,
Transcription factors (gold) and their leading‐edge targets (ie, genes contributing most to the TFs' significance) from the GSEA TF‐target analysis.
Red circles indicate significant DEGs. Dashed lines indicate protein‐protein interactions between the target genes (see Section 2)
maternal opioid history, or main effects of diet and maternal opioid
history).
We analyzed Gene Ontology (GO) enrichment in this set of 168
differentially expressed genes using ClusterProfiler25 to obtain a com-
prehensive understanding of the overrepresented functional catego-
ries. Genes down‐regulated with morphine in the FSD‐maintained
animals were enriched for 31 GO biological process terms (FDR p
adjust <.05; see Figure 5B). Modulation of chemical synaptic transmis-
sion was the most significantly enriched biological process among
these genes. Based on the similarity of the differentially expressed
genes in each term, the enriched pathways in genes down‐regulated
in MORF1 males were further clustered into four major categories
that can broadly be described as synaptic plasticity, transporter activ-
ity, calcium ion transport, and synapse organization and axonogenesis
(Figure 5B). These categories are consistent with the suggestion that
molecular mechanisms of neuronal signaling in the ARC of MORF1
males are impaired when those males are maintained on a FSD. In con-
trast, the set of differentially expressed genes up‐regulated in MORF1
males was enriched for 80 GO biological process terms (after remov-
ing highly similar and redundant terms). These clustered into several
broad categories, including coagulation, fatty acid and xenobiotic met-
abolic processes, response to interleukin‐6, peptidase activity, plasma
lipoprotein particle clearance, and viral entry into host cells (Figure 5
C).
GSEA26 differs from the above analyses because genes that do not
change enough to appear significant at an individual gene level may
nonetheless show a significant pattern as part of a coordinately func-
tioning gene set. Full GSEA results appear in Data S2. Applying GSEA
with the “c2 canonical pathways” gene sets from MSigDB26 revealed a
significant induction of complement and coagulation cascades, ECM
regulators, cytokine‐cytokine receptor interaction, and drug metabo-
lism/cytochrome p450 in MORF1 FSD‐maintained males. Interest-
ingly, the PPAR signaling pathway was found among the top
significant up‐regulated pathways. Moreover, pathways involved in
neuronal systems, voltage gated potassium channels, and amine ligand
binding receptors were significantly repressed in MORF1 FSD‐main-
tained males.
Further, to attempt to identify regulators of the observed gene
expression dynamics between FSD‐maintained MORF1 and SALF1
males, we performed GSEA with gene set collections corresponding
to transcription factor targets (part of the c3 collection in MSigDB)
or those genes affected by various genetic and chemical perturbations
in prior experiments (part of the c2 collection). Hnf1 was the only tran-
scription factor whose targets were significantly up‐regulated in
MORF1 males, while Rest, Foxn1, Ahr, and E2F1 targets were signifi-
cantly down‐regulated in MORF1 males (see Figure 5D). Of the
genetic and chemical perturbations gene set collection, the gene set
“MEISSNER NPC HCP with H3K4ME2 and H3K27ME3” was among
the most significantly differentially regulated gene sets whose mem-
bers were down‐regulated in MORF1 males, along with other curated
gene sets characterizing methylation patterns, suggesting a role for
histone methylation and chromatin structure in the MORF1 response.
Top gene candidates identified via differential expression (Cyp2c7)
and GSEA (PPARγ and Hnf1a) were also examined by qPCR to provide
additional validation of sequencing results (Data S1; Figure 3).
4 | DISCUSSION
Opioid use among females of reproductive age remains at historically
high levels, despite efforts to reduce prescribing rates.3 When consid-
ering opioid use in the context of reproductive outcomes, the primary
focus is often on continuing use during pregnancy and effects on the
fetus and newborn infant. Moreover, when potential long‐term out-
comes of fetal opioid exposure are hypothesized, they often focus
on neurocognitive effects related to behavioral regulation. Yet effects
of both exogenous and endogenous opioids on glucose regulation
have been appreciated for decades.28 Indeed, increased risk for type
2 diabetes in breast cancer survivors correlates with cumulative opioid
use29 and increased prevalence of metabolic syndrome is reported in
opioid dependent patients.30 The current findings, however, suggest
that this increased risk is not limited to the female consuming these
drugs but can also extend to future progeny.
Metabolic diseases, including obesity and diabetes, are major pub-
lic health issues of growing concern.31 In the human population,
parental and grandparental experiences (ie, stress and nutritional sta-
tus), even those experiences occurring prior to conception, can predis-
pose future progeny to metabolic disease.32,33 Thus, in addition to the
effects of the fetal and postnatal environment, transgenerational epi-
genetic inheritance may also moderate the risk of metabolic dis-
ease.34,35 While parental exposures to drugs of abuse have been
demonstrated to alter reward pathways in nonexposed offspring,36,37
the primary focus has been on substance use disorder. The current
findings demonstrate that effects of maternal opioid use prior to preg-
nancy extend beyond substance abuse liability and include alterations
in metabolic and neuroendocrine regulation with potential health con-
sequences that are exacerbated in environments in which high fat and
sugary diets are the norm.
In the present study, delayed sexual maturation in MORF1 males
served as an early indicator of neuroendocrine disruption, even before
any diet‐induced effects were observed. It is possible that such neuro-
endocrine changes influenced subsequent physiological effects
induced by HSD in MORF1 males. Moreover, initiating the HSD diet
during pubertal development may have resulted in more profound
effects on MORF1 males than had the diet been initiated in adulthood.
Indeed, previous findings have observed profound effects on hypotha-
lamic transcription in preclinical models that initiate a high sugar diet
during adolescence but not in adulthood.38 In response to mainte-
nance on FSD, MORF1 males went on to demonstrate increased
bodyweight gain, fasting glucose, insulin, and corticosterone as well
as increased ARC NPY. The higher bodyweights were not due to dif-
ferences in locomotor activity. Rather, MORF1 males were generally
hyperphagic under FSD conditions, an effect associated with elevated
expression of NPY, a potent orexigen. Of note, the NPY inactive pre-
cursor, proNPY, was increased in MORF1 males irrespective of dietary
condition. Such findings suggest that MORF1 males may be
predisposed to metabolic dysfunction, displaying increased baseline
expression of proNPY, with counter‐regulatory post‐translational
mechanisms in place to suppress NPY production under CD but not
once animals are metabolically challenged with FSD.
Similarly, POMC peptide was significantly increased in CD‐main-
tained MORF1 males. One hypothesis is that this up‐regulation could
serve as a counter‐regulatory homeostatic mechanism in a phenotype
prone toward a positive energy balance. The effect on POMC was not
observed under FSD conditions, suggesting that diet may challenge
this regulatory mechanism in MORF1 males. Thus, under FSD condi-
tions, these compensatory mechanisms are disrupted leading to a pos-
itive energy balance and glucose dyshomeostasis. As differences in
POMC were observed under control conditions, we speculated that
up‐regulation of this anorexogenic peptide may play a role in the prop-
agation of this phenotype. Indeed, previous studies demonstrate that
fetal alcohol exposure induces hypermethylation of Pomc, and this epi-
genetic mark is maintained over three generations and is associated
with later life adult‐onset disease.39 Because hypomethylation of
the distal Pomc promoter increases POMC expression,40 we assessed
the Pomc locus for changes in methylation status under baseline
conditions. However, DNA methylation within the Pomc locus was
similar between SALF1 and MORF1 males. This suggests that the
observed differences in POMC expression are regulated by other
mechanisms.
To assess the functional effects of differential ARC POMC expres-
sion, α‐MSH and β‐EP levels were examined in PVN and VTA, where
they are known to augment energy balance and metabolism via recep-
tor‐mediated stimulation of neuronal targets.41 Under the CD condi-
tion, MORF1 males had reduced levels of α‐MSH within the PVN,
even in the presence of increased ARC POMC expression. This effect
was not observed under FSD conditions. Thus, findings suggest dimin-
ished melanocortin tone within the PVN of MORF1 males, and further
support the notion that even under the CD conditions, these animals
are primed for a metabolically adverse phenotype.42 Within the VTA,
no differences in α‐MSH were observed, demonstrating region‐spe-
cific modifications in POMC‐derived neuropeptide distribution.
Under FSD conditions, MORF1 males display increased β‐EP levels
within the VTA, which may contribute to the observed increase in
bodyweight, as β‐EP signals within the VTA promote a positive energy
balance.43 Moreover, β‐EP reduces POMC activity via an
autoregulatory mechanism44; thus, a β‐EP mediated inhibition of
POMC activity in MORF1 males may account for the absence of dif-
ferences in ARC POMC expression in FSD‐maintained MORF1 males.
In addition, as subthreshold amounts of β‐EP suppress the metabolic
effects induced by α‐MSH, 45 it is likely that FSD‐fed MORF1 males
may also have diminished melanocortin tone within the VTA. Notably,
increasing melanocortin signaling within the VTA protects against the
development of diet‐induced obesity.46 Thus, altered α‐MSH and β‐EP
activity within the PVN and VTA is associated with the adverse
MORF1 metabolic phenotype. Furthermore, elevated β‐EP levels
within the VTA suggest that the hedonic value of food in FSD MORF1
males may be elevated, resulting in increased caloric intake. Such an
outcome may suggest significant differences in reward valence of pal-
atable food as a consequence of maternal opioid history. We have
previously measured self‐administration of sucrose pellets in MORF1
males (fixed ratio and progressive ratio) and did not observes any sig-
nificant differences when compared with SALF1 males47; however, it
is possible that either the high fat component of the FSD or the
continuous availability of this highly palatable food stimulated
increased feeding behaviors in MORF1 males. Indeed, endogenous
opioids have been demonstrated to influence the hedonic value of
highly palatable food,48 suggesting that dysregulation of opioid modu-
lation of reward systems, similar to what we have observed in previ-
ous studies.11,13
Impairments in glucose homeostasis also emerged in FSD‐MORF1
males. To examine more proximal mechanisms underlying MORF1
fasting hyperglycemia, insulin and CORT were also evaluated. While
CD‐F1 males display comparable fasting plasma insulin, FSD‐MORF1
males demonstrate elevated insulin when compared with FSD‐SALF1
males. Previous studies suggest, similar to our findings in FSD‐SALF1
males, chronic exposure to high fat diets diminish the
hyperinsulinemia that is observed when animals are first transitioned
to a high fat diet.49 Such an effect suggests that the normal adapta-
tions observed in response to maintenance on a FSD are modified
based on maternal opioid history resulting in early the emergence of
insulin resistance in FSD‐MORF1 males, a pathologic condition that
mediates the prediabetic/diabetic state.50 Future studies are needed
to assess insulin sensitivity in central and peripheral tissues with
respect to the role of insulin in facilitating MORF1 glucose dysregula-
tion. Nonetheless, our current data reveals that MORF1 males are
predisposed to the development of type 2 diabetes following only 6
weeks on an obesogenic diet. The metabolic profile of FSD‐MORF1
males suggests an increased risk for the development of metabolic
syndrome51; as such, it is expected that MORF1 males would be sus-
ceptible to the development of associated comorbidities (ie, cardiovas-
cular disease and hypertension).
FSD‐MORF1 males also displayed increased levels of CORT, which
may contribute to the hyperglycemic state as elevated CORT levels
are gluconeogenic.52 While elevated NPY likely plays a role in the
hyperphagia demonstrated by FSD‐maintained MORF1 males, NPY
also positively regulates the HPA axis, thus increasing CORT output.53
Indeed, NPY, CORT, and insulin are regulated in tandem to affect mul-
tiple aspects of energy homeostasis. Thus, elevated levels of NPY may
result in increased CORT. It is also possible that MORF1 males are
more sensitive to activation of the HPA axis induced by fasting condi-
tions, resulting in increased CORT, which may then increase NPY
expression and gluconeogenesis despite elevated insulin levels. Impor-
tantly, these effects are only observed in MORF1 males following
maintenance on the FSD, indicative of an interaction between mater-
nal opioid history and diet condition on hypothalamic regulation of
homeostatic processes critical for regulating both feeding behavior
and glucose regulation.
To further provide an unbiased assessment of hypothalamic modi-
fications related to both maternal opioid history and diet, transcrip-
tional changes in the ARC were examined using RNAseq. Effects of
maternal opioid history only reached significance in FSD‐maintained
F1 males. The overall pattern of these changes implicate down‐
regulation of genes associated with synaptic plasticity and neurotrans-
mission coincident with up‐regulation of immune, inflammatory, and
metabolic‐related genes. It should be noted that neither the POMC
nor the NPY gene reached significance in our sequencing analysis,
although we have previously observed significant up‐regulation in
the POMC gene in MORF1 males10,13 and protein expression was sig-
nificantly impacted by both maternal opioid history and diet. Given the
large number of genes probed via sequencing and the statistical cor-
rections required for multiple comparisons, the failure to observe sig-
nificant effects on relatively small changes in gene expression was not
unexpected, particularly given that RNA sequencing was conducted
under fasting conditions, which likely induced a robust transcriptional
response. Indeed, it was for those reasons that we opted to focus our
analysis on gene sets rather than on individual gene targets, as signif-
icant differences in homeostatic processes that develop over a
protracted period of time in response to dietary intake likely result in
subtle changes in gene expression across coordinated gene networks
rather than having a large effect on single gene targets.
The use of gene set enrichment analyses confirm and extend these
findings, identifying a number of pathways that may a play a role in the
metabolic dyshomeostasis observed in FSD‐maintained MORF1 males
and which suggest additional risk for adult‐onset disease under these
conditions. For example, the peroxisome proliferator‐activated recep-
tor (PPAR) signaling pathway was significantly up‐regulated in FSD‐
MORF1 males. Interestingly, not only is this pathway implicated in
nutritional regulation of metabolism54 but it is also a potential link
between metabolic dysregulation and cancer.55 Up‐regulation of one
member of this pathway, PPARγ, was significantly increased in FSD‐
MORF1 males when measured using qPCR (Figure S3). Additionally,
a number of transcription factors whose targets showed significant
FIGURE 6 Schematic of findings, potential mechanisms, and potential risks
dysregulation were identified using GSEA, including Hnf1, a transcrip-
tion factor linked with mature onset diabetes of the young.56 Pro-
tein‐protein interactions connecting the targets of the transcription
factors modified in FSD‐MORF1 males were also noted (Figure 5D),
while other significant gene set enrichment implicates modifications
in histone methylation within the hypothalamus of FSD‐maintained
MORF1 males. Thus, the impact on neurodevelopmental processes
appears to involve multiple regulatory mechanisms, not only transcrip-
tional regulation but also protein‐protein interactions and chromatin
accessibility. These analyses demonstrate the power of using gene sets
to identify shifts in the transcriptional landscape, as opposed to simply
examining differences in individual genes. Indeed, while dysregulation
of the Hnf1a transcription factor was identified in FSD‐MORF1 males,
expression of Hnf1a was only significantly up‐regulated in MORF1 CD
males when examined using qPCR (Figure S3). Overall, these data point
to the capacity for maternal opioid exposure prior to conception to
fundamentally alter transcriptional responses under particular dietary
conditions in a brain region critical for homeostasis.
As summarized in Figure 6, these findings suggest that MORF1
males are innately primed for metabolic dyshomeostasis, which is
revealed at an early age in response to a relatively brief (6 week) die-
tary challenge. Thus, a maternal history of opioid exposure interacts
with F1 offspring diet to disturb hypothalamic and neuroendocrine
systems that influence sexual maturation, energy metabolism, synaptic
plasticity, and likely immune function mediated by profound changes
in the arcuate nucleus of the hypothalamus. Many of the observed
effects on gene transcription and metabolic function increase the risk
that MORF1 males will develop other pathologies including other met-
abolic diseases (ie, cardiovascular disease), neurodevelopmental disor-
ders, and potentially cancer.
We conclude that maternal opioid exposure prior to conception
increases the risk that future male offspring will develop type 2
diabetes when maintained for a relatively brief period on a diet high
in fat and sugar. These findings implicate maternal opioid exposure,
even when use is discontinued prior to pregnancy, as a potential risk
factor for the adult onset of metabolic dysfunction in the next
generation.
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